4,137,902 Shares IMMUNICON CORPORATION Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • June 29th, 2005 • Immunicon Corp • Laboratory analytical instruments • New York
Contract Type FiledJune 29th, 2005 Company Industry JurisdictionImmunicon Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to issue and sell 4,137,902 shares (the “Shares”) of common stock, $0.001 par value per share (the “Common Stock”), directly to certain investors (collectively, the “Investors”). The Company desires to engage you as its placement agents (the “Placement Agents”) in connection with such issuance and sale. The Shares are more fully described in the Registration Statement (as hereinafter defined).
3,336,117 Shares OXIGENE, INC. Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • March 7th, 2005 • Oxigene Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 7th, 2005 Company Industry JurisdictionOXiGENE, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to issue and sell shares (the “Shares”) of common stock, $0.01 par value per share (the “Common Stock”), directly to certain investors (collectively, the “Investors”). The Company desires to engage you as its placement agents (the “Placement Agents”) in connection with such issuance and sale. The Shares are more fully described in the Registration Statement (as hereinafter defined).
2,570,000 Shares CYTOGEN CORPORATION Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 15th, 2004 • Cytogen Corp • Pharmaceutical preparations • New York
Contract Type FiledApril 15th, 2004 Company Industry JurisdictionCytogen Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to issue and sell shares (the “Shares”) of common stock, $0.01 par value per share (the “Common Stock”), directly to certain investors (collectively, the “Investors”). The Company desires to engage you as its placement agents (the “Placement Agents”) in connection with such issuance and sale. The Shares are more fully described in the Registration Statement (as hereinafter defined).
4,100,000 Shares VAXGEN, INC. Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • December 8th, 2003 • Vaxgen Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 8th, 2003 Company Industry Jurisdiction